These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6883939)

  • 1. Toxicities of amoxapine.
    Ereshefsky L
    Clin Pharm; 1983; 2(2):104, 107-8. PubMed ID: 6883939
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistent tardive dyskinesia associated with amoxapine therapy--two case reports.
    Huang CC
    Hillside J Clin Psychiatry; 1986; 8(2):209-13. PubMed ID: 3557296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent tardive dyskinesia associated with amoxapine therapy.
    Huang CC
    Am J Psychiatry; 1986 Aug; 143(8):1069-70. PubMed ID: 3728738
    [No Abstract]   [Full Text] [Related]  

  • 4. Withdrawal dyskinesia following amoxapine therapy.
    Price WA; Giannini AJ
    J Clin Psychiatry; 1986 Jun; 47(6):329-30. PubMed ID: 3711034
    [No Abstract]   [Full Text] [Related]  

  • 5. [Amoxapine. An antidepressant responsible for extrapyramidal side effects?].
    Matot JP; Ziegler M; Olie JP; Rondot P
    Therapie; 1985; 40(3):187-90. PubMed ID: 4012664
    [No Abstract]   [Full Text] [Related]  

  • 6. Case report of withdrawal dyskinesia associated with amoxapine.
    Weller RA; McKnelly WV
    Am J Psychiatry; 1983 Nov; 140(11):1515-6. PubMed ID: 6625005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dyskinesia associated with amoxapine antidepressant therapy: a case report.
    Lapierre YD; Anderson K
    Am J Psychiatry; 1983 Apr; 140(4):493-4. PubMed ID: 6837795
    [No Abstract]   [Full Text] [Related]  

  • 8. Case report of withdrawal dyskinesia associated with amoxapine.
    Lesser I
    Am J Psychiatry; 1983 Oct; 140(10):1358-9. PubMed ID: 6624971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Case report of tardive dyskinesia and parkinsonism associated with amoxapine therapy.
    Thornton JE; Stahl SM
    Am J Psychiatry; 1984 May; 141(5):704-5. PubMed ID: 6711697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amoxapine-induced tardive dyskinesia.
    Tao GK; Harada DT; Kootsikas ME; Gordon MN; Brinkman JH
    Drug Intell Clin Pharm; 1985; 19(7-8):548-9. PubMed ID: 4028958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Akathisia induced by amoxapine.
    Ross DR; Walker JI; Peterson J
    Am J Psychiatry; 1983 Jan; 140(1):115-6. PubMed ID: 6847973
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety of amoxapine.
    Devarajan S
    Lancet; 1989 Dec; 2(8677):1455. PubMed ID: 2574384
    [No Abstract]   [Full Text] [Related]  

  • 13. Amoxapine-induced seizures: case reports.
    Giannini AJ; Price WA
    J Clin Psychiatry; 1984 Aug; 45(8):358-9. PubMed ID: 6146603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dyskinesia associated with amoxapine withdrawal and use of carbamazepine and antihistamines.
    McMahon T
    Psychosomatics; 1986 Feb; 27(2):145-6, 148. PubMed ID: 3952257
    [No Abstract]   [Full Text] [Related]  

  • 15. Alcohol, amoxapine, and akathisia.
    Shen WW
    Biol Psychiatry; 1984 Jun; 19(6):929-30. PubMed ID: 6743727
    [No Abstract]   [Full Text] [Related]  

  • 16. Amoxapine-induced extrapyramidal effects.
    Price WA
    Psychosomatics; 1986 Jun; 27(6):464, 468. PubMed ID: 3737838
    [No Abstract]   [Full Text] [Related]  

  • 17. Adverse reactions due to dopamine blockade by amoxapine. A case report and review of the literature.
    Hunt-Fugate AK; Zander J; Lesar TS
    Pharmacotherapy; 1984; 4(1):35-9. PubMed ID: 6701099
    [No Abstract]   [Full Text] [Related]  

  • 18. Amoxapine: a cause of toxic epidermal necrolysis?
    Camisa C; Grines C
    Arch Dermatol; 1983 Sep; 119(9):709-10. PubMed ID: 6614956
    [No Abstract]   [Full Text] [Related]  

  • 19. Amoxapine-induced cognitive impairment in two patients.
    Burns A; Tune L
    J Clin Psychiatry; 1987 Apr; 48(4):166-7. PubMed ID: 3558331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of neuroleptic malignant syndrome during simultaneous amoxapine treatment and alprazolam discontinuation.
    Burch EA; Downs J
    J Clin Psychopharmacol; 1987 Feb; 7(1):55-6. PubMed ID: 3818996
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.